KEMPHYS LTD has a total of 24 patent applications. Its first patent ever was published in 2005. It filed its patents most often in EPO (European Patent Office), United States and China. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are LIMERICK BIOPHARMA INC, METAPROTEOMICS LLC and ACASTI PHARMA INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 7 | |
#2 | United States | 6 | |
#3 | China | 4 | |
#4 | Japan | 4 | |
#5 | WIPO (World Intellectual Property Organization) | 3 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Name | Total Patents |
---|---|---|
#1 | Shudo Koichi | 18 |
#2 | Ishido Miwako | 6 |
#3 | Muratake Hideaki | 5 |
#4 | Sugiyama Kiyoshi | 5 |
#5 | Ito Ai | 4 |
#6 | Katsumura Naoko | 4 |
#7 | Kagechika Hiroyuki | 3 |
#8 | Koichi Shudo | 3 |
#9 | Naoko Katsumura | 2 |
#10 | Miwako Ishido | 2 |
Publication | Filing date | Title |
---|---|---|
US2016206624A1 | Medicament for treatment of Alzheimer's disease | |
EP2910560A1 | Silicon-containing carboxylic acid derivative | |
EP2946777A1 | Medicine for treatment of neuropathic disease | |
EP2730559A1 | Deuterated phenylpropionic acid derivative | |
JP2012225892A | Method for removing radioactive material from solution | |
JP2013147427A | Pharmaceutical agent for prevention and/or treatment of htlv-i-associated myelopathy | |
WO2009101684A1 | Drug for preventing and/or treating visceral fusion | |
US2008207768A1 | Medicament for preventive and/or therapeutic treatment of lower urinary tract symptom | |
EP1930001A1 | Pharmaceutical for use in prevention and/or treatment of bowel disease |